Efficacy of Posterior Pharyngeal Wall Injection for Velopharyngeal Dysfunction in Adults

被引:0
|
作者
Arora, Nikhil [1 ]
Young, VyVy N. [1 ]
Schneider, Sarah L. [1 ]
Ma, Yue [1 ]
Rosen, Clark A. [1 ]
Crosby, Tyler W. [1 ]
机构
[1] Univ Calif San Francisco, Sch Med, Dept Otolaryngol Head & Neck Surg, San Francisco, CA USA
关键词
injection pharyngoplasty; posterior pharyngeal wall injection; velopharyngeal deficiency; velopharyngeal insufficiency; AUTOLOGOUS FAT INJECTION; PERCEPTUAL EVALUATION; IMPORTANT DIFFERENCE; INSUFFICIENCY; PHARYNGOPLASTY; HYPERNASALITY; AUGMENTATION; RELIABILITY; DIAGNOSIS; VALIDITY;
D O I
10.1002/lary.31788
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective(s)Posterior pharyngeal wall (PPW) injection is often employed to treat velopharyngeal deficiency (VPD). We sought to analyze the impact of PPW injection on severity of dysphagia and dysphonia.MethodsRetrospective chart review was conducted of patients undergoing PPW injection from 2018 to 2023 at a tertiary laryngology center. Effects on Voice Handicap Index-10 (VHI-10), Eating Assessment Tool-10 (EAT-10), soft palate closure on modified barium swallow, and auditory-perceptual measures of hypernasality and audible nasal air emission were analyzed.Results67 PPW injections were performed in 29 patients (11 female). Mean age was 59.4 +/- 17.0 years. Etiologies were head and neck cancer (n = 23) and neurologic conditions (n = 6). 30 PPW injections were performed concurrent with intervention on the upper esophageal sphincter (25 dilations, 3 myotomies, 2 botulinum toxin injections), and 8 with a glottic procedure (6 vocal fold injections, 2 thyroplasties). Change scores were 3.87 (-6.85 to -0.89, p = .012) for VHI-10 and -3.00 (-4.75 to -1.25, p = 0.001) for EAT-10. These were statistically different from 0 for the whole cohort but not in the subset of patients undergoing concurrent voice and/or swallow surgery. Soft palate closure scores tended to be better (but not statistically significant) on MBS after PPW injection. Hypernasality and audible nasal air emission both improved after injection.ConclusionPPW injection appears to have a therapeutic effect on dysphagia/dysphonia in patients with VPD; however, many patients have multifactorial impairment. Additional study is needed to determine benefit of PPW when performed in conjunction with other procedures in this complex patient population.Level of EvidenceLevel 4 (Case series) Laryngoscope, 2024 In this article, we describe the impact of posterior pharyngeal wall (PPW) injection augmentation in adult patients with velopharyngeal deficiency (VPD) in term of its impact on subjective measures of dysphagia and dysphonia. Herein, we provide additional support for efficacy of this treatment while highlighting the complexity of this patient population, who often exhibit multifactorial deficiencies in speech and swallow.image
引用
收藏
页码:605 / 613
页数:9
相关论文
共 34 条
  • [31] Defining Risk of Postoperative Obstructive Sleep Apnea in Patients With 22q11.2DS Undergoing Pharyngeal Flap Surgery for Velopharyngeal Dysfunction Using Polysomnographic Evaluation
    Lee, Alfred
    Chang, Brian L.
    Solot, Cynthia
    Crowley, Terrence B.
    Vemulapalli, Vamsee
    McDonald-McGinn, Donna M.
    Maguire, Meg Ann
    Mason, Thornton B. A.
    Elden, Lisa
    Cielo, Christopher M.
    Jackson, Oksana A.
    CLEFT PALATE-CRANIOFACIAL JOURNAL, 2020, 57 (07) : 808 - 818
  • [32] Efficacy of intra-meibomian gland injection of the anti-VEGF agent bevacizumab for the treatment of meibomian gland dysfunction with lid-margin vascularity
    Jiang, Xiaodan
    Wang, Yuexin
    Lv, Huibin
    Liu, Yan
    Zhang, Mingzhou
    Li, Xuemin
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 1269 - 1279
  • [33] Efficacy of two injection-site localisation techniques for botulinum toxin injections: a single-blind, crossover, randomised trial protocol among adults with hemiplegia due to stroke
    Morel, Claire
    Hauret, Isabelle
    Andant, Nicolas
    Bonnin, Armand
    Pereira, Bruno
    Coudeyre, Emmanuel
    BMJ OPEN, 2016, 6 (11):
  • [34] Efficacy and safety of AZR-MD-001 selenium sulfide ophthalmic ointment in adults with meibomian gland dysfunction over six months of treatment: A Phase 2, vehicle-controlled, randomized extension trial
    Downie, Laura E.
    Craig, Jennifer P.
    Stapleton, Fiona
    Tan, Jacqueline
    Jones, Lyndon W.
    Ng, Alison
    Hinds, Mark
    Bosworth, Charles
    Alster, Yair
    OCULAR SURFACE, 2025, 35 : 15 - 24